The role of clinical trials in psychiatric practice - pros and cons issues
The role of clinical trials in psychiatric practice - pros and cons issues

Summary/Abstract: The big pharmaceutical companies spend on average 800 million dollars to develop a molecule from the stage of “idea” to the market launch; the small and biotechnology companies spend about 250 million up to 500 million dollars. Most of these expenses are for both clinical trials and marketing. In the field of psychiatry, the first controlled clinical trial was conducted in 1922, by Nicholas Kopeloff, a bacteriologist at the New York State Psychiatric Institute, along with the psychiatrist Clarence O'Cheney.

• Details
• Contents